NCT01594736View on ClinicalTrials.gov

ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Coronary Heart Disease
Interventions
DRUG

ORSIRO

due randomization ORSIRO will be implanted

DEVICE

XIENCE PRIME DES

due randomization XIENCE PRIME DES will be implanted

Trial Locations (2)

80636

Deutsches Herzzentrum München, Munich

81675

Klinikum rechts der Isar, Munich

All Listed Sponsors
collaborator

Technical University of Munich

OTHER

lead

Deutsches Herzzentrum Muenchen

OTHER

NCT01594736 - ORSIRO Stents Versus Xience PRIME Stents Assessed by Optical Coherence Tomography | Biotech Hunter | Biotech Hunter